This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Curium US LLC. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Sven V Gerritsen: Innovator in Xenon-133 Production
Introduction
Sven V Gerritsen is a notable inventor based in Alkmaar, Netherlands. He has made significant contributions to the field of nuclear medicine through his innovative methods for producing Xenon-133. With a total of 2 patents, his work is pivotal in enhancing the efficiency of medical isotopes.
Latest Patents
Gerritsen's latest patents focus on systems and methods for the production of Xenon-133. One of the methods disclosed involves collecting off gas from a Molybdenum-99 production process in a storage tank. This off gas contains both Xenon-133 and Krypton-85. The method includes selectively adsorbing Xenon-133 from the off gas onto a charcoal column assembly, ensuring that Xenon-133 is preferentially adsorbed compared to Krypton-85. Additionally, the process involves desorbing the Xenon-133 from the charcoal column by heating the assembly and condensing the gas within a coil assembly.
Career Highlights
Sven V Gerritsen is currently associated with Curium US LLC, where he continues to develop innovative solutions in the field of radiopharmaceuticals. His expertise in the production of medical isotopes has positioned him as a key player in the industry.
Collaborations
Gerritsen has collaborated with notable colleagues, including Luis Antonio M M Barbosa and Martinus J A Schackmann. These partnerships have further enhanced the research and development efforts in the production of Xenon-133.
Conclusion
Sven V Gerritsen's contributions to the production of Xenon-133 are invaluable to the field of nuclear medicine. His innovative methods and collaborative efforts continue to advance the efficiency of medical isotope production.